Shin Nippon Biomedical Laboratories, Ltd. (TYO:2395)

TYO:2395 Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 2, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	58,326	63,197	114,488	70,608	29,101	21,982
Market Cap Growth	-1.77%	-44.80%	62.15%	142.63%	32.39%	-41.40%
Enterprise Value	82,459	76,952	122,471	74,176	36,794	32,906
Last Close Price	1401.00	1463.63	2572.85	1557.71	626.92	460.10
PE Ratio	11.80	11.43	18.89	9.91	7.95	8.62
Forward PE	10.79	-	-	-	-	-
PS Ratio	1.90	2.39	4.56	3.98	1.93	1.51
PB Ratio	1.30	1.85	4.34	3.58	1.84	1.34
P/TBV Ratio	1.62	1.98	4.67	3.65	1.88	1.37
P/FCF Ratio	-	-	16.01	7.91	11.76
P/OCF Ratio	30.01	28.59	11.86	6.13	7.28
EV/Sales Ratio	2.69	2.91	4.88	4.18	2.44	2.26
EV/EBITDA Ratio	9.35	12.76	17.89	13.81	9.90	9.52
EV/EBIT Ratio	12.21	18.49	23.35	17.68	14.55	14.76
EV/FCF Ratio	-	-	16.82	10.00	17.60
Debt / Equity Ratio	0.76	0.77	0.71	0.46	0.80	0.91
Debt / EBITDA Ratio	6.10	4.34	2.74	1.70	3.41	4.32
Debt / FCF Ratio	-	-	-	2.07	3.45	7.98
Asset Turnover	0.36	0.40	0.52	0.47	0.40	0.31
Inventory Turnover	1.19	1.24	2.06	1.91	1.87	1.82
Quick Ratio	0.60	0.69	0.73	0.79	0.86	0.60
Current Ratio	1.21	1.31	1.14	1.21	1.24	0.96
Return on Equity (ROE)	12.98%	18.24%	26.26%	40.30%	22.82%	11.80%
Return on Assets (ROA)	2.61%	3.90%	6.79%	6.88%	4.16%	2.99%
Return on Capital (ROIC)	3.23%	4.93%	8.86%	9.14%	5.28%	3.68%
Return on Capital Employed (ROCE)	5.00%	7.90%	14.50%	16.20%	10.10%	8.60%
Earnings Yield	8.47%	8.75%	5.29%	10.09%	12.58%	11.60%
FCF Yield	-10.25%	-0.73%	6.25%	12.64%	8.51%
Dividend Yield	3.49%	3.42%	1.94%	1.93%	1.59%	1.09%
Payout Ratio	0.00%	37.48%	41.01%	11.60%	5.65%	4.82%
Buyback Yield / Dilution	-0.00%	-	0.00%	-	-	-
Total Shareholder Return	3.49%	3.42%	1.94%	1.93%	1.59%	1.09%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.